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Abstract. Gold nanoshells (GNSs) were grown on monodispersed and 
aminopropyltriethoxysilane (APTES) functionalized silica nanoparticles (NPs) cores with 
varying sizes ranging from 60-180 nm, which were prepared by Stober route. Gold shells were 
deposited onto the surface of silica NPs by using tetrakis(hydroxymethyl) phosphonium chloride 
(THPC) and an electroless gold plating method. The coverage of the gold nanoshells on the 
surfaces of the silica NPs was evaluated using surface plasmon resonance (SPR) spectra and 
scanning electron microscope (SEM). The GNSs were also attached with biomolecules. The 
plasmon resonance wavelengths of this GNSs were tunable from visible to near infrared. The 
attachment process of biomolecules onto the GNSs surfaces was controlled by measuring both 
their SPR spectra and their zeta potentials.  
Keywords:  gold nanoshells, surface plasmon resonance, zeta potential. 
Classification numbers: 2.1.1; 2.4.4; 2.5.1 
1. INTRODUCTION 
Gold nanoshells (GNSs) nanoparticles (NPs) consist of a spherical dielectric core coated 
with a concentric layer of gold [1]. Due to large extinction cross sections of GNSs between 700-
1200 nm, it is possible to use them in biological applications such as hyperthermia agents, 
contrast agents biological imaging, controlled drug release, bioprobes in cell and tissue analysis, 
and for studying biological processes at the nanoscale [2, 3, 4, 5]. A critical factor limiting the 
applications of GNSs for therapeutic and diagnostic purposes is their short circulation time in 
vivo due to clearance by the body’s reticuloendothelial system [6]. For the biomedical 
application, particularly for in vivo imaging it requires stable GNSs in biological media. 
Therefore, the surface biofunctionalization of the GNSs is necessary for their applications. 
General strategies are provided for the covalent and noncovalent mode of binding based on a 
combination of electrostatic and hydrophobic interactions of the biomolecules or biocompatible 
molecules onto the gold surface. These GNSs were attached with some kinds of alive 
biomolecules such as glutathione (GSH), protein bovine serum albumin (BSA), and anti-HER2 
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IgG monoclonal antibody [7]. Glutathione is an important tripeptide in all living organisms. It is 
one of important biological antioxidants, preventing damage to important cellular components 
caused by reactive oxygen species such as free radicals and peroxides. In a previous work, we 
reported about the binding of GSH onto the GNSs surfaces [8]. Serum albumin is a major 
protein component of blood plasma but is distributed to the interstitial fluid of the body tissues. 
Serum albumin is capable of binding to a wide variety of drugs, and there is strong interest in 
this abundant protein because of its effects on drug delivery. Therefore, immobilization and 
immunoreaction of a fundamental protein, such as serum albumin on gold NPs, is very important 
for bioapplications [7]. These GNSs were also conjugated with a biocompatible molecules, HS-
PEG-COOH due to its stealth character with immune system [9]. Moreover, modified thiol–PEG 
(SH-PEG) is an excellent candidate for stabilizing gold NPs in physiological condition, and 
enabling long lasting circulation in the blood [10].   
In this paper we focus on the preparation and the biofunctionalization of GNSs. The 
coverage of the GNSs on the surfaces of the silica NPs was evaluated using UV-VIS/NIR 
spectroscopy. The surphase plasmon resonance (SPR) wavelengths of these GNSs were tunable 
from visible to near infrared.  Simultaneously, this work is to use the SPR spectra to monitor the 
biomolecules coating process onto GNNs NPs, on which we can determinate the suitable 
biomolecule amounts to obtain stability GNSs. The biofunctionalization of GNS NPs was 
estimated by dynamic light scattering (DLS) measurement. The results demonstrate the effects 
of the biomolecules layer on zeta potential values. This work also gives us how to determine the 
threshold of biomolecules binding onto the GNSs surfaces. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Tetraethylorthosilicate (TEOS, 99 %), ammonium hydroxide (NH4OH, 29 % in water), and 
glutathione were purchased from Sigma–Aldrich. APTES (99 %); ethanol, tetrachloroauric acid 
trihydrate (HAuCl4 .3H2O, 99.9 %), Tetrakis(hydroxymethyl)phosphonium chloride (THPC,             
80 % solution in water), sodium hydroxide (NaOH, 99 %), potassium carbonate (99 %), and 
formaldehyde (37 % solution in water) were purchased from Merck. Bovine serum albumin was 
obtained from Biochem. The heterobifunctional thiol polyethylene glycol acid with a molar 
weight of 1000 Dalton (HS-PEG-COOH) was purchased from Creative PEG works. The mouse 
anti-HER2 IgG monoclonal antibody (anti-HER2 IgG) (28-0003z) 1 mg/mL in PBS solution 
with pH 7.4 with 1 % BSA was purchased from Invitrogen. Deionized (DI) water was used in all 
experiments. 
2.2. Preparation and biofunctionalization of gold nanoshells 
GNSs were prepared by the seed-and-grow method which details were described in our 
previous work [11], using silica core with a diameter of 60-180 nm synthesized by Stober route. 
The particle surface was then terminated with amine groups by reaction with APTES. THPC 
gold NPs (1-2 nm) were prepared by the method of Duff et al. [12].  
The size and stability of THPC gold were obviously improved by using citrate buffer of 4,6 
mM. 1 ml of APTES functioned of silica NPs was then added to 3 ml of THPC gold NPs 
solution. THPC gold NPs were absorbed into the amine groups on the silica NPs surface 
resulting in an APTES functioned silica NP decorated with discrete of THPC gold NPs, called 
 
 




the ‘seeds' NPs. The 10-20 nm gold shell layers were then grown on these ‘seeds' through the 
electroless gold plating process by using gold plating solution in the presence of formaldehyde.  
After the preparation of GNSs NP solution, in order to avoid the GNS NPs’s aggregation or to 
make the GNSs solutions more stable and to biofunctionalize these GNSs for the future 
biomedical applications, the GNS NPs were bioconjugated with GSH, BSA, HS-PEG-COOH 
and anti-HER2 IgG molecules. 
 
Figure 1. Schematic of GNS NPs was conjugated with biomolecules: GSH, HS-PEG-COOH, BSA                 
and anti-HER2 antibody IgG. 
Figure 1 presents the schematic of GNS NPs, which were conjugated with different 
biomolecules. The biofunctionalization process of each biomolecule was performed according to 
our previous works:  with HS-PEG-COOH [4], with GSH [11];  with BSA [13,14],  and  with 
anti-HER2 IgG [14]. In brief, a number of above biomolecules was added into the GNS NPs 
solution to generate biomolecules-coated GNS NPs. The process was done by stirring the 
solution for 1 hour at room temperature. The suitable amounts of these biomolecules to coat 
GNSs NPs were estimated from a collection of their UV-VIS/NEAR spectra during their storage 
time in dark and at 4 
o
C.  
2.3. Characterizations of gold nanoshells 
The absorption spectra of GNS NPs and their biofunctionalized GNS NPs solutions were 
collected on a Shimadzu UV2600 spectrophotometer. Scanning electron microscopy (SEM) 
images of the GNPs NPs were obtained from HITACHI SEM S4800 microscope. The 
polydispersity index (PDI) values and zeta potentials of the bare and biofunctionalized GNS NPs 
were measured by dynamic light scattering (DLS) technique with an angle scattering of 173
0
 
(Nano ZS, Malvern).  
3. RESULTS AND DISCUSSION 
3.1. The formation of gold nanoshells 
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The formation and characterization of GNSs with different sizes of a silica core coated with 
various coverage of gold shell were detailed in our previous work [11]. The SEM images in 
Figure 2 show the morphologic properties of GNS NPs obtained from silica core NPs with the 
corresponding sizes of 180 ± 5 nm and 70 ± 3 nm coated with gold shells with the thickness of 
about of 15 nm. The coverage was uniform regardless of silica NPs core sizes. 
 
 
Figure 2.  SEM images of silica NPs core with sizes of 180 ± 5 nm (A) and of 70± 3 nm (B)                     
coated with gold shells.  
3.2. Optical characterizations and biofunctionalization of gold nanoshells 
Important information pertaining to the aggregation state and the stability of conjugated 
GNS NPs can be obtained from SPR spectra before and after the biofunctionalization process. 
Figure 3 shows the SPR absorption spectra of GNS NPs with sizes of 100 nm before (Fig. 3a) 
and after being coated with BSA molecules observed during two weeks of storage (Fig. 3b).  
  
Figure 3. SPR spectra of 100 nm-size (a) bare GNSs NPs during 2 weeks storage; and (b) GNSs NPs 
coated with a different amount of BSA protein after two weeks storage. 
As shown in Figure 3a, the absorbance of bare GNS NPs was strongly decreased after 3 
days of storage. The previous work of Neoh and Kang reported that the absorbed BSA proteins 




[15]. Due to the surface of GNSs NPs can not be 
exactly determined, our GNS NPs were coated with a different amount of protein BSA, i.e. from 
 
 




25 µg/mL-125 µg/mL. Their absorbances have insignificantly changed during two weeks of 
storage (Fig. 3b). 
This result indicates that without BSA coating, the bare GNS NPs solution has a tendency 
of aggregation, as resulted from their instability, so the GNSs coated with a layer of BSA protein 
are expected to be prevented from the aggregation of GNSs NPs. In fact, we observed the GNS 
NPs@BSA proteins are more stable. According to this result, we can also determine the 
threshold or suitable amount of BSA to stabilize the GNS NPs solution. 
  
Figure 4. SPR spectra of GNSs NPs observed after two weeks storage of 100 nm in-size GNS NPs:                  
(a) coated with different amount of PEG; (b) coated with different amount of GSH. 
Owing to the strong binding between thiols to noble metals, the HS-PEG-COOH and GSH, 
thiol-containing molecules were frequently used to stabilize the gold NPs [15]. Similarly to our 
approach, different amounts of HS-PEG-COOH, GSH were used to coat the GNSs, and their 
SPR spectra were also measured during the storage time. The results showed that the suitable 
amounts to stabilize GNSs are about 25 µg/mL for GSH, and 110 µg/mL for HS-PEG-COOH, 
respectively,  as indicated in Figures 4a and 4b. Observing the SPR spectra of the GNSs coated 
with biomolecules during storage time, we could determine their suitable amounts to stabilize 
the GNSs. These results fit with the previous report of Widrid et al. that the required n-
alkanethiols binding onto the gold surface is about 5-6 molecules/nm
2 
[16].  
Figure 5 presents the SPR spectra of GNSs coated with the suitable amounts of different 
biomolecules as detailed in Table 1, corresponding to two different sizes shown in Figure 2. The 
results show that for the samples without coating the SPR intensity of GNSs decreases over 
storage time. In contrast, when GNSs were coated with these biomolecules, their SPR spectra 
shapes exhibited almost no change, while the SPR intensity increased by 5 to 10 percent (Figure 
5a). In addition, their SPR spectra are slightly red-shift, i.e. of about 4 - 5 nm as shown in Figure 
5b. These results correspond with the modeling of B. Dan and co-worker [17] on the SRP of a 
single protein conjugated GNS and with our previous studies [7] and, indicated that these 
biomolecules are successfully conjugated with GNS NPs. According to zeta potential 
measurement, the obtained data of GNSs coated with different above bimolecules in ultra pure 
water correspond with the above suitable amounts. Figure 6 presents the obtained zeta potential 
diagrams of bare GNS NPs and after being conjugated with BSA, GSH, PEG and IgG/BSA. The 
zeta potential of the GNS NPs increased from -31 mV (before binding) to -18 mV (after 
conjugation with biocompatible molecule HS-PEG-COOH). 
 
 





Figure 5.  The SPR spectra of GNSs NPs of 200 mm size (a), and normalized SPR spectra of                        
GNSs NPs of 100 nm size (b), coated by different biomolecules. 
 
Figure 6.   Zeta potential distribution of bare GNS NPs and after being conjugated with                          
BSA, GSH, PEG and IgG/BSA. 
Meanwhile, the binding of BSA, GSH or IgG/BSA onto the surface of GNSs NPs made 
their zeta potentials slightly decreased as shown in Table 1. Particularly, with the antibody IgG 
molecule stabilizer in BSA solution, the obtained zeta potential has two peaks at - 47 mV and - 
30 mV. The zeta potential value of GNSs NPs solution depends on the nature of molecules 
bounded on the GNSs NPs surface. These results demonstrated that various functional groups on 
 
 




the nanoparticles surface exhibited different surface zeta potential values. This result again 
demonstrated that these biomolecules are successfully conjugated with GNS NPs.  
Table 1. Zeta potentials (ξ) of the GNSs conjugated with biomolecules and biocompatible molecules. 
SamplesGNS NPs 




SiO2@Au - -31.9 
SiO2@Au@BSA  50 µg BSA -33.9 
SiO2@Au@PEG-COOH 165 µg PEG -18.6 
SiO2@Au@GSH 25 µg GSH - 42.3 
SiO2@Au@IgG/BSA 25 µg BSA+2.5 µg IgG -47 and -30 
4. CONCLUSIONS 
In conclusion, we report a simple way to form the GNSs from the silica NPs core of various 
sizes ranging from 70 to 180 nm. The SPR of the GNSs could be adjusted to any wavelength 
from the visible to the NIR region of the electromagnetic spectrum. The biofunctionalization 
process of bio-molecules onto the GNSs surfaces was controlled by observing their SPR spectra 
during two weeks storage. Simultaneously, the biofunctionalization process could help us to 
estimate the agent amount suitable to cover the GNSs NPs or particle density. The GNSs were 
successfully attached by various biomolecules or biocompatible molecules, making them ready 
for biomedical applications. 
Acknowledgements. We acknowledge the funding from project VAST.CTVL.02/17-18, and Basic 
Research Project of Institute of Physic, VAST.   
REFERENCES 
1. Oldenburg S., Averitt R., Westcott S. and Halas N. - Nanoengineering of optical   
resonances, Chem. Phys. Lett. 288 (2–4) (1998) 243–247. 
2. Huang X., Jain P. K., El-Sayed I. H., and El-Sayed M. A. - Plasmonic photothermal 
therapy (PPTT) using gold nanoparticles, Lasers Med. Sci. 23 (3) (2008)  217–228. 
3. Singhana B., Slattery P., Chen A., Wallace M. and Melancon M. P. - Light-Activatable 
Gold Nanoshells for Drug Delivery Applications, AAPS Pharm Sci Tech. 15 (3) (2014) 
741–752. 
4. Huang X. and El-Sayed M. A. - Gold nanoparticles: Optical properties and 




Biofunctionalization of Gold Nanoshells Monitored by Surface Plasmon Resonance 
  
611 
5. Wang Y., Qian W., Tan Y. and Ding S. - A label-free biosensor based on gold nanoshell 
monolayers for monitoring biomolecular interactions in diluted whole blood, Biosens. 
Bioelectron. 23 (7) (2008) 1166–1170. 
6. Owensiii D., and Peppas N. - Opsonization, biodistribution, and pharmacokinetics of 
polymeric nanoparticles, Int. J. Pharm. 307 (1) (2006) pp. 93–102. 
7. Nghiem T. H. L,. La T.H., Vu X. H., Chu V. H., Nguyen T. H., Le Q.H., Fort E., Do Q.H. 
and Tran H. N. - Synthesis, capping and binding of colloidal gold nanoparticles to 
proteins, Adv. Nat. Sci. Nanosci. Nanotechnol.  1 (2) (2010)  025009. 
8. Kim C., Ghosh P. and Rotello V. M. - Multimodal drug delivery using gold nanoparticles, 
Nanoscale 1 (1) (2009)  61. 
9. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., 
Katayama Y., Niidome Y. - PEG-modified gold nanorods with a stealth character for in 
vivo applications, J. Controlled Release 114 (3) (2006) 343–347. 
10. von Maltzahn G., Park J-H, Agrawal A, Bandaru NK, Das SK, Sailor MJ, et al. - 
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold 
Nanorod Antennas, Cancer Res.  69 (9) (2009) 3892–3900. 
11. Nghiem T. H. L., Le T. N., Do T. H., Vu T. T. D., Do Q. H. and Tran H. N. - Preparation 
and characterization of silica–gold core–shell nanoparticles, J. Nanoparticle Res. 15 (11) 
(2013) 1-9. 
12. Duff D. G., Baiker A., and Edwards P. P. - A new hydrosol of gold clusters. 1. Formation 
and particle size variation, Langmuir  9 (9) (1993)  2301–2309. 
13.  Nghiem T. H. L., Nguyen T. T., Fort E., Nguyen T.P., Hoang T. M. N., Nguyen T.Q. and 
Tran H.N. - Capping and in vivo toxicity studies of gold nanoparticles, Adv. Nat. Sci. 
Nanosci. Nanotechnol. 3(1) (2012)  015002. 
14. Neoh K. G. and Kang E. T. - Functionalization of inorganic nanoparticles with polymers 
for stealth biomedical applications,  Polym Chem.  2 (4) (2011) 747–759. 
15. Hermanson G. T. - Bioconjugate techniques. Amsterdam: Academic Press, 2008. 
16. Widrig C. A., Chung C. and Porter M. D. - The electrochemical desorption of n-
alkanethiol monolayers from polycrystalline Au and Ag electrodes, J. Electroanal. Chem. 
Interfacial Electrochem. 310 (1–2) (1991) 335–359. 
17. Dan B. and Hu C.-K. - Plasmon resonance based analysis of a single protein conjugated 
Au nanoshell, Biointerphases  9 (3) (2014)   031017. 
